Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy.
about
Proteomic profiling in multiple sclerosis clinical courses reveals potential biomarkers of neurodegenerationChondroitin sulfate proteoglycans in the nervous system: inhibitors to repairReduction of disease activity and disability with high-dose cyclophosphamide in patients with aggressive multiple sclerosisMitochondrial defects in acute multiple sclerosis lesionsZinc in Multiple Sclerosis: A Systematic Review and Meta-AnalysisMultiple sclerosis: molecular mechanisms and therapeutic opportunitiesNeuro-endocrine networks controlling immune system in health and diseaseTracking CNS and systemic sources of oxidative stress during the course of chronic neuroinflammationIs Multiple Sclerosis an Autoimmune Disease?Magnetic resonance imaging of human brain macrophage infiltrationMechanisms underlying inflammation in neurodegenerationCXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosisA combined post-mortem magnetic resonance imaging and quantitative histological study of multiple sclerosis pathology.Diagnostic biomarkers in multiple sclerosis.P-glycoprotein acts as an immunomodulator during neuroinflammation.Emerging therapies in multiple sclerosis.Quantification of normal-appearing white matter tract integrity in multiple sclerosis: a diffusion kurtosis imaging study.Methylprednisolone inhibits interleukin-17 and interferon-gamma expression by both naive and primed T cellsDiffusion imaging in multiple sclerosis: research and clinical implications.Targeting FcRn for therapy: from live cell imaging to in vivo studies in mice.Expression profiles of endoplasmic reticulum stress-related molecules in demyelinating lesions and multiple sclerosis.Cytokines as Biomarkers of Treatment Response to IFN β in Relapsing-Remitting Multiple SclerosisA unique antibody gene signature is prevalent in the central nervous system of patients with multiple sclerosis.Applied neurogenomics.The blood-brain barrier in health and disease.Eae19, a new locus on rat chromosome 15 regulating experimental autoimmune encephalomyelitis.Nervous system pathology: the fibrin perspective.Estrogen and testosterone therapies in multiple sclerosis.Extensive cortical remyelination in patients with chronic multiple sclerosis.The pathology of primary progressive multiple sclerosis.Molecular mechanisms underlying the effects of statins in the central nervous system.Production of IL-16 correlates with CD4+ Th1 inflammation and phosphorylation of axonal cytoskeleton in multiple sclerosis lesions.Heterogeneity versus homogeneity of multiple sclerosis.Multiple sclerosis as a by-product of the failure to sustain protective autoimmunity: a paradigm shift.Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation.Adipocytokine profile, cytokine levels and foxp3 expression in multiple sclerosis: a possible link to susceptibility and clinical course of disease.Myelin associated glycoprotein cross-linking triggers its partitioning into lipid rafts, specific signaling events and cytoskeletal rearrangements in oligodendrocytes.Disease-modifying therapies in multiple sclerosis: an update on recent and ongoing trials and future strategies.Relationships between quantitative spinal cord MRI and retinal layers in multiple sclerosis.New approaches to investigating heterogeneity in complex traits
P2860
Q21131975-FF8D0EF4-24F2-46DD-A7D6-BEEADCF6AA87Q21284516-7A30FA26-57C5-4341-8A0F-CA92B7A916B3Q24647406-82BE87BF-F639-4FE5-99C3-51F145F392EFQ24648580-D9591C73-C278-42F1-8EEB-E931B8F4219BQ26747289-FBAC8CEF-990D-4CE6-B12F-D6690A277160Q27023735-078B39FF-3EDA-43E3-93DC-D6DFF285F59EQ27026101-09A6ED42-7EA1-4681-9927-D8E8D428EE16Q27322415-6718EA0D-73FB-4882-8244-A57E2AF844E7Q27496011-9B25E178-16D5-4047-BB53-736E2E57B394Q28307827-70F8B376-936F-4944-AB95-B75D25769A20Q29617977-006D26FD-8269-4F2F-8753-6E2D1CD8F127Q30493331-094C31C8-B6E0-4E80-88C4-712BD99175D4Q30525646-320AEE48-5242-47D7-89AD-16C79D4ED7F2Q30598338-5F660954-D37F-46F1-816D-C13E369A8E4FQ30973736-EDFE7346-2E67-485E-BB71-925DDF8E390AQ31015100-628F4251-B97A-43AF-AFA1-010526EFCA49Q31081056-3DB480F3-32B9-4B35-AF6E-FE1FF05169FAQ33359750-90BAC383-ED8D-4A17-85B8-1AAD9617F2F0Q33706390-80EC3DA1-202B-4777-98E4-AA7CD1B3B1B9Q33758483-C5351A33-330B-4EFE-846B-9ABE9F05287DQ33839043-716504B1-CC62-44A2-9B1D-8F6314B38611Q34053077-E9F4FF8F-1EA3-4BFD-BD09-7EBAC6A08450Q34117793-884854E6-503D-4124-979D-DFBB9120D1B3Q34258228-71CB514F-C558-41A3-BD1C-19BA55AD873AQ34320420-052FCD95-6EEF-43F4-8D20-62C5C12B9448Q34573223-28D75660-EFE8-42CD-ABFF-30CDFC5B3C67Q34584793-C46C121F-ADB9-47A6-9460-33B3580082B6Q34610594-44AF4459-8573-41AA-9623-FE8A743FEFF7Q34612670-D6294315-4F0D-4E7F-84F2-69B53CF12ED9Q34625041-9723CC73-30E4-4DB0-A47D-FE27D1065D21Q34685463-D560A9C9-869D-4B9D-B7B2-4888FE943028Q34715993-8C81933D-2920-4431-AE0F-56025D88A12DQ34893931-FEAD34D1-EB54-4170-8FEE-3E3B1EE1C48DQ34956279-F4A0AFD3-C841-4CA4-ABFE-CBDA5303D4CDQ35009513-EAD5F624-84D9-4F29-A62E-983C601A9F8AQ35009543-F433F9B9-22F7-49DB-9897-6A4965706A3BQ35040508-F193DEDB-F645-4F74-8FBE-073B210BF8C3Q35094706-C7BE2349-3ADA-44B4-AD55-623E1DA22D22Q35106595-6BF62CF0-819D-4AB1-BB90-894B3BC80443Q35200318-5A9B540A-A708-41EF-8C02-7CD8BD282F2D
P2860
Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy.
@ast
Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy.
@en
type
label
Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy.
@ast
Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy.
@en
prefLabel
Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy.
@ast
Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy.
@en
P1476
Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy
@en
P2093
C Lucchinetti
P304
P356
10.1016/S1471-4914(00)01909-2
P577
2001-03-01T00:00:00Z